article thumbnail

IXCHIQ Chikungunya Vaccine Trial Shows Sustained Immune Response in Adolescents

XTalks

The study included 754 adolescents, comparing immune responses and safety profiles between vaccine and placebo groups. Chikungunya, a mosquito-borne viral disease, causes severe joint pain, fever and rash, with symptoms that can linger for months or even years.

article thumbnail

Strong immune response underlies acute kidney injury related to COVID-19

Scienmag

— Mayo Clinic researchers have found that acute kidney injury associated with COVID-19 resembles sepsis-caused kidney injury, and the immune response triggered by the infection plays a pivotal role. ROCHESTER, Minn.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Innovation in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Worldwide Clinical Trials

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research 147
article thumbnail

China’s NMPA accepts IND for SinoMab BioScience’s SM17 to treat asthma

Pharmaceutical Technology

It can suppress Th2 immune responses by binding to IL-17RB on Type 2 innate lymphoid cells (ILC2s). This blocks a cascade of responses that are induced by interleukin-25 (IL-25), a critical cytokine which is classified as ‘alarmin’.

article thumbnail

Innovating in Autoimmune and Bone Health Research: Driving Progress for Better Patient Outcomes

Worldwide Clinical Trials

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research 130
article thumbnail

Itolizumab Shows Positive Phase III Results in First-Line Treatment of Acute GVHD

XTalks

It occurs when immune cells from the donor perceive the host tissues as foreign and subsequently initiate an immune response against them. Despite the use of corticosteroids as the standard first-line treatment, many patients fail to achieve a sustained response, leading to high rates of morbidity and mortality.

article thumbnail

Novocure’s TTFields Therapy Shows Survival Benefit in Pancreatic Cancer

XTalks

This multifaceted mechanism not only targets the structural integrity of cancer cells but also enhances immune responses and increases tumor permeability to improve the efficacy of other treatments. Novocure’s broader pipeline underscores the versatility of TTFields therapy.

Trials 105